Oslo, 14 April 2020: In connection with the Annual General Meeting of Ultimovacs
ASA to be held on 23 April 2020, Jónas Einarsson, Chairman of the Board of
Directors, has so far received proxy based voting rights without voting
instructions for 8,169,626 shares, representing 29.32% of the total voting
rights in the company. 

With the addition of the 1,395,875 shares controlled by Radforsk, Jónas
Einarsson thus represents a total of 9,565,501 shares. This corresponds to
34.33% of the company's total number of shares and votes in connection with the
company's ordinary Annual General Meeting. 

The proxies are only valid for the Annual General Meeting on 23 April 2020. 

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.


For further information, please see www.ultimovacs.com or contact:

Jónas Einarsson, Chairman of the Board of Directors of Ultimovacs ASA
je@radforsk.no, +47 480 96 355

Øyvind Kongstun Arnesen, CEO 
oeyvind.arnesen@ultimovacs.com, +47 469 33 810 

Hans Vassgård Eid, CFO 
hans.eid@ultimovacs.com, +47 469 19 822